Specialties

Metformin may help lower the risk of cardiovascular events and death in patients with moderate to severe renal function.

This may not be an actual “physical” disaster averted yet because we don’t know the long-term effects on the people who have taken the ARBs and possibly other medications that were tainted with carcinogens or other “poisons.” When we (health care providers) were first notified of this issue, my first …

Intensive diabetes therapy can be associated with excess weight gain, central obesity, and dyslipidemia with increased heart disease risk.

Specific A1c, glucose ranges associated with diabetes-specific vision impairment.

Lifestyle intervention in pregnancy might reduce adverse effects of maternal obesity on neonatal adiposity.

Monitoring glucose in midlife may help prevent future cardiovascular disease, according to a study published in Diabetes Care.

Dapagliflozin’s updated package insert confirms efficacy and safety profile for patients with moderate chronic kidney disease.

Paula Trief, PhD received her PhD in Clinical Psychology from Syracuse University. She joined the faculty at SUNY Upstate Medical University in the Department of Psychiatry & Behavioral Sciences in 1993. She is currently a tenured Distinguished Service Professor of Psychiatry & Behavioral Sciences, with joint appointments in the departments of Medicine and Orthopedic Surgery. Academically, she is an active behavioral science researcher, studying behavioral interventions for patients with diabetes. Her current RO1 studies factors that predict medication adherence and healthcare usage in emerging adults with type 2 diabetes.

In this Exclusive Interview transcript, psychologist Paula Trief talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the role of mental health in diabetes and how partners of people with diabetes can be of support in diabetes care.

In this Exclusive Interview, psychologist Paula Trief talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about how partners of people with diabetes can be of support in diabetes care.